Charles J. Dockendorff - Aug 18, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Aug 18, 2023
Transactions value $
-$866,631
Form type
4
Date filed
8/18/2023, 04:10 PM
Previous filing
Aug 8, 2023
Next filing
Sep 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale -$867 K -17.1 K -81.23% $50.74 3.95 K Aug 18, 2023 Direct F1, F2
holding BSX Common Stock 42.6 K Aug 18, 2023 By Spouse's Trust
holding BSX Common Stock 17.4 K Aug 18, 2023 By Trust

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 19, 2023.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $50.455 to $50.95, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.